Inhibition of PLK1 Destabilizes EGFR and Sensitizes EGFR-Mutated Lung Cancer Cells to Small Molecule Inhibitor Osimertinib

Research output: Contribution to journalArticlepeer-review

3 Citations (Scopus)
41 Downloads (Pure)

Fingerprint

Dive into the research topics of 'Inhibition of PLK1 Destabilizes EGFR and Sensitizes EGFR-Mutated Lung Cancer Cells to Small Molecule Inhibitor Osimertinib'. Together they form a unique fingerprint.

Medicine & Life Sciences